ArticleCancer science2012

Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo.

Mayumi Komachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.